OneMedNet (ONMDW) Stock: Why It's Down Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
ONMDW slides 8.8% to $0.03. Closed at $0.03, -8.84% vs the prior close of $0.03. Day range $0.02–$0.03, opened at $0.15.
ONMDW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — ONMDW slides 8.8% to $0.03
- Closed at $0.03, -8.84% vs the prior close of $0.03. Day range $0.02–$0.03, opened at $0.15.
- 52-week range $0.02–$0.03; today's close sits at 79% of that range, 8.8% below the 52-week high.
ONMDW bull case vs bear case (from the data)
- Annual revenue grew 111.4% in the latest fiscal year (SEC XBRL).
- Insiders made 25 open-market purchases in the last 12 months.
- Latest fiscal-year net income: loss of $2.80M.
- Share count up 28.6% in a year (dilution).
- High volatility: average daily move of 8.8% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
ONMDW latest news & SEC filings
Every SEC filing by or about ONMDW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kosasa Thomas bought 129,758 shares at $5.78 (≈$750.00K) on Oct 7, 2026; now holds 1,983,573
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Yu Jeffrey bought 45,126 shares at $5.54 (≈$250.00K) on Oct 9, 2026; now holds 896,840
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Golden Robert Lawrence received an award of 10,000 shares on Jan 1, 2026; now holds 64,791
- Golden Robert Lawrence received an award of 35,000 shares on Jul 6, 2026; now holds 99,791
- Golden Robert Lawrence sold 2,500 shares at $6.60 (≈$16.50K) on Sep 14, 2026; now holds 97,291
- Golden Robert Lawrence sold 3,000 shares at $6.30 (≈$18.90K) on Sep 15, 2026; now holds 94,291
- Golden Robert Lawrence sold 3,000 shares at $6.63 (≈$19.89K) on Sep 21, 2026; now holds 91,291
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Green Aaron received an award of 65,000 shares on Jul 6, 2026; now holds 254,638
- Green Aaron sold 5,000 shares at $7.39 (≈$36.96K) on Sep 22, 2026; now holds 249,638
- Green Aaron sold 1,667 shares at $6.48 (≈$10.80K) on Sep 24, 2026; now holds 247,971
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 30, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Yu Jeffrey bought 142,857 shares at $0.63 (≈$90.00K) on Sep 10, 2026
- Yu Jeffrey bought 142,857 shares at $0.63 (≈$90.00K) on Sep 10, 2026
- Yu Jeffrey bought 142,857 shares at $0.63 (≈$90.00K) on Sep 10, 2026
- Yu Jeffrey bought 142,857 shares at $0.63 (≈$90.00K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 20, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 20, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 19, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $292.00K (prior year $155.00K) (+88.4% vs Jun 30, 2025)
- Net income: -$2.17M (prior year $2.98M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.04 (prior year $0.07) (loss widened vs Jun 30, 2025)
Aug 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kosasa Thomas bought 1,449,275 shares at $0.69 (≈$1,000.00K) on Jul 30, 2026
- Kosasa Thomas bought 1,449,275 shares at $0.69 (≈$1,000.00K) on Jul 30, 2026
- Kosasa Thomas bought 1,449,275 shares at $0.69 (≈$1,000.00K) on Jul 30, 2026
- Kosasa Thomas bought 1,449,275 shares at $0.69 (≈$1,000.00K) on Jul 30, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade ONMDW
- Last results release: May 23, 2024 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 8.84% (largest 8.8%). That is a volatile stock.
- Liquidity: about 2.55K shares (≈$76) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.03 vs a range of $0.02–$0.03 (79% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Jeffrey Yu bought 142,857 shares on Sep 10, 2026.
- Latest filings: 8-K Oct 14, 2026; 8-K Sep 29, 2026; 8-K Sep 23, 2026.
- Share count: 59.29M shares outstanding (Aug 11, 2026), +28.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Commercial Physical & Biological Research.
ONMDW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.15 | 0.03 | 0.02 | 0.03 | 5.10K |
| Oct 6, 2026 | 0.15 | 0.03 | 0.03 | 0.03 | 0 |
About OneMedNet
OneMedNet (ONMDW) is listed on the Nasdaq and classified by the SEC under “Services-Commercial Physical & Biological Research”. Its business address is in SURREY, United Kingdom. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1849380.
ONMDW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kenneth Alleyne | Director | Nov 26, 2025 |
| Eric Casaburi | Director | Nov 26, 2025 |
| Jair Clarke | Director | Nov 26, 2025 |
| Robert Lawrence Golden | Chief Financial Officer | Nov 26, 2025 |
| Aaron Green | Chief Executive Officer | Jun 24, 2026 |
| Thomas Kosasa | Director | Aug 7, 2026 |
| Sherry Coonse Mccraw | Director | Nov 26, 2025 |
| Jeffrey Yu | Chief Medical Officer | Sep 14, 2026 |
| Andrew B Zeinfeld | Director | Nov 26, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robert Lawrence Golden | Chief Financial Officer | Nov 26, 2025 |
| Aaron Green | Chief Executive Officer | Jun 24, 2026 |
| Jeffrey Yu | Chief Medical Officer | Sep 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 10, 2026 | Jeffrey Yu | Buy | 142,857 | $0.63 |
| Sep 10, 2026 | Jeffrey Yu | Buy | 142,857 | $0.63 |
| Sep 10, 2026 | Jeffrey Yu | Buy | 142,857 | $0.63 |
| Sep 10, 2026 | Jeffrey Yu | Buy | 142,857 | $0.63 |
| Jul 30, 2026 | Thomas Kosasa | Buy | 1,449,275 | $0.69 |
| Jul 30, 2026 | Thomas Kosasa | Buy | 1,449,275 | $0.69 |
| Jul 30, 2026 | Thomas Kosasa | Buy | 1,449,275 | $0.69 |
| Jul 30, 2026 | Thomas Kosasa | Buy | 1,449,275 | $0.69 |
| Jun 23, 2026 | Jeffrey Yu | Buy | 158,730 | $0.63 |
| Jun 23, 2026 | Jeffrey Yu | Buy | 158,730 | $0.63 |
| Jun 23, 2026 | Jeffrey Yu | Buy | 158,730 | $0.63 |
| Jun 23, 2026 | Jeffrey Yu | Buy | 158,730 | $0.63 |
| Jun 23, 2026 | Aaron Green | Buy | 36,650 | $0.57 |
| Jun 23, 2026 | Aaron Green | Buy | 36,650 | $0.57 |
| Jun 23, 2026 | Aaron Green | Buy | 36,650 | $0.57 |
ONMDW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.36M | $-2.80M | -0.06 | $-7.50M |
| Dec 31, 2024 | $643.00K | $-10.13M | -0.36 | $-6.95M |
| Dec 31, 2023 | $1.02M | $-33.78M | -4.65 | $-4.79M |
| Dec 31, 2022 | $1.15M | $-6.23M | 0.03 | $87.24M |
| Dec 31, 2021 | — | $5.14M | 0.44 | $-378.49K |
Latest balance sheet: total assets $1.36M, total liabilities $4.88M, cash $358.00K (as of Jun 30, 2026).
ONMDW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 23, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Commercial Physical & Biological Research
Iqvia (IQV)Charles River Laboratories International (CRL)Incyte (INCY)Medpace (MEDP)Icon (ICLR)Absci (ABSI)bioAffinity Technologies (BIAF)OmniAb (OABI)Nrc Health (NRC)Maxcyte (MXCT)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on ONMDW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.